News Coverage - Parker Institute for Cancer Immunotherapy

Research
Network
News
About
Donate

Research
Network
- Research Institutions
  Our academic collaborators’ seminal contributions push the field forward
- Directory
  Our constellation of renowned thinkers and partners
- Strategic Partnerships
  The right collaborators across pharma, biotech and nonprofit
- Early Career Researcher Awards
  The next generation of scientific leaders in cancer immunotherapy
News
- News Menu
  - The Latest
    Stories & Announcements
  - News Coverage
    PICI in the News
  - Podcast
    From Bench to Fireside
  - For Media
    Resources for Press
About
- Mission & Vision
  Develop breakthrough immune therapies to turn all cancers into curable diseases faster
- Leadership & Staff
  The driving force behind PICI’s research and operations
- Careers
  Join us. Change lives.
Donate

STAT

01.04.18

3 game-changing biotechnologies to watch in 2018

Read

STAT News

01.03.18

The NIH is in danger of losing its edge in creating biomedical innovations

Read

Washington Post

01.02.18

New cancer treatments have perplexing side effects

Read

GEN News

12.21.17

Meet the Scientist Who Helped Discover a Class of Potent Cancer Drugs

Read

Endpoints News

12.20.17

Parker Institute-allied Tessa grabs an $80M round for its next-gen cancer cell therapies

Read

Nature

12.20.17

Calling cancer’s bluff with neoantigen vaccines

Read

Nature

12.20.17

Making cancer immunotherapy a surer bet

Read

Fortune

12.15.17

Supercharging Philanthropy

Read

Fierce Biotech

12.04.17

A novel immuno-oncology approach to treating a rare childhood brain cancer

Read

Hutch News

11.30.17

Fred Hutch immunologist Dr. Phil Greenberg joins Parker Institute for Cancer Immunotherapy

Read

CNBC

11.28.17

CNBC launches Healthy Returns, a conference focusing on health care innovation

Read

Oncology Times

11.25.17

Gut Bacteria Modulates Response to Immunotherapy in Melanoma

Read